GID8
Chr 20GID complex subunit 8 homolog
Also known as: C20orf11, TWA1
The GID8 protein is a core component of the CTLH E3 ubiquitin ligase complex that regulates protein degradation and acts as a positive regulator of Wnt signaling by promoting beta-catenin nuclear accumulation. This gene is highly constrained against loss-of-function variants (pLI 0.94, LOEUF 0.36), but no specific Mendelian diseases have been definitively associated with GID8 mutations to date. Additional clinical and genetic evidence is needed to establish clear genotype-phenotype correlations for this gene.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
More LoF-intolerant than ~75% of genes
Moderately missense-constrained (top ~2.5%)
ClinVar Variant Classifications
77 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 0 | 0 | 26 | 0 | 26 |
Likely Pathogenic | 0 | 0 | 6 | 0 | 6 |
VUS | 0 | 20 | 16 | 0 | 36 |
Likely Benign | 0 | 0 | 2 | 0 | 2 |
Benign | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 20 | 50 | 0 | 70 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
GID8 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →External Resources
Links to major genomics databases and tools